| # | % | |||||
|---|---|---|---|---|---|---|
| 1551 | ALEXION PHARMACEUTIC | 129,802 | 20,282,000 | 0.89% | ||
| 1552 | JOHNSON & JOHNSON | 247,874 | 25,933,000 | 1.14% | ||
| 1553 | MICROSOFT CORP | 630,550 | 26,294,000 | 1.15% | ||
| 1554 | INTEL CORP | 1,075,965 | 33,247,000 | 1.46% | ||
| 1555 | EXXON MOBIL CORP | 340,027 | 34,234,000 | 1.50% | ||
| 1556 | APPLE INC | 471,735 | 43,838,000 | 1.92% | ||
| 1557 | CELGENE CORP | 522,930 | 44,909,000 | 1.97% | ||
| 1558 | BIOGEN INC | 154,233 | 48,631,000 | 2.13% | ||
| 1559 | ABBVIE INC | 957,997 | 54,069,000 | 2.37% | ||
| 1560 | AMGEN INC | 494,806 | 58,570,000 | 2.57% | ||
| 1561 | GILEAD SCIENCES INC | 1,001,839 | 83,062,000 | 3.64% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-14-001552, filed 2014.08.08).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
